Innovega is developing a transformative eyewear system called eMacula that combines smart contact lenses and stylish glasses. The system will provide unprecedented assistance to the 15 million visually impaired through magnification and enhancement of the wearer's vision. It will also open new mass consumer markets by offering normal, stylish glasses that provide augmented and virtual reality experiences. Innovega has assembled a team with experience from Microsoft, Sony, and Bausch + Lomb and has investors including Tencent. Clinical trials are underway and FDA approval is being pursued to bring the innovative product to market.
Richard L. Lindstrom, MD's "Thoughts on Corneal and Lens based Refractive Surgery to Enhance Near Vision in the USA: 2015" presentation from OIS@ASCRS 2015
Lissa's mda presentation keynote short copy oct 12 2013 copyJody Abrams
The document discusses low vision rehabilitation for patients with macular degeneration. It outlines the goals of regaining independence with daily activities through specialized training and low vision devices. A low vision exam evaluates remaining functional vision and trials magnification devices. Occupational therapists provide eccentric viewing training and device instruction. While insurance may cover exams and training, patients typically pay for devices. Options include telescopic glasses, magnifiers, video magnifiers, adapted lighting and computer programs. The overall purpose is helping patients adapt rather than restoring sight.
Cataract surgery is a common outpatient procedure that involves replacing the cloudy natural lens with an artificial lens through mild sedation and topical anesthetic. There are several lens replacement options, including monofocal lenses which often require glasses after surgery, and premium lenses like toric lenses to reduce astigmatism or multifocal lenses that provide distance, intermediate, and near vision with over 80% of patients needing no glasses or contacts after surgery.
The Right Contact - Up to date information regarding contact lenses, Hyrid lenses, Soft lenses, button materials, gas permable lens and contact lens care products.
This document discusses the implantable miniature telescope (IMT) for treating end-stage age-related macular degeneration. It provides the following information:
1) The IMT received FDA approval in 2009 and Medicare coverage in 2011-2012 for patients with untreatable end-stage AMD who meet clinical criteria.
2) Clinical trials showed the IMT significantly improved vision for most patients, with 67% gaining 3 or more lines of vision and quality of life improvements.
3) The CentraSight treatment program assesses patients' candidacy and provides pre-and post-operative management including low vision rehabilitation to help patients utilize their restored vision.
Adaptive lenses can solve key issues preventing virtual and augmented reality from reaching their potential by changing focus like the human eye. They allow VR and XR experiences to be more immersive and comfortable by resolving the vergence-accommodation conflict. Adaptive lenses paired with eye tracking could also create autofocus glasses that automatically adjust focus for the user. Adaptive lenses are needed to fully realize the market potential of AR/VR estimated at over $50 billion by allowing content to be viewed comfortably at close distances.
Team 18 is developing a modular attachment for optical microscopes that uses Quantitative Phase Imaging (QPI) technology to provide faster, cheaper, and more accurate results for cancer and blood disorder research compared to state-of-the-art instrumentation. They have over 100 customers including universities, bio-pharma companies, and OEMs. Key members include experts in noninvasive biomedical imaging and entrepreneurship with experience commercializing start-up technologies.
This document discusses cataracts and presbyopia, as well as treatment options performed by Dr. Helga Fuenfhausen Pizio. A cataract is a clouding of the eye's lens that causes vision problems and is common in older adults. Symptoms include blurry or faded vision. Surgery is the only treatment and involves removing the clouded lens and replacing it with an artificial lens. For presbyopia, which causes near vision issues, multifocal lenses can provide both near and distance vision after cataract surgery without glasses. Dr. Pizio performs cataract surgery using small incisions and ultrasound and was the first in Nevada to implant a new multifocal lens.
Richard L. Lindstrom, MD's "Thoughts on Corneal and Lens based Refractive Surgery to Enhance Near Vision in the USA: 2015" presentation from OIS@ASCRS 2015
Lissa's mda presentation keynote short copy oct 12 2013 copyJody Abrams
The document discusses low vision rehabilitation for patients with macular degeneration. It outlines the goals of regaining independence with daily activities through specialized training and low vision devices. A low vision exam evaluates remaining functional vision and trials magnification devices. Occupational therapists provide eccentric viewing training and device instruction. While insurance may cover exams and training, patients typically pay for devices. Options include telescopic glasses, magnifiers, video magnifiers, adapted lighting and computer programs. The overall purpose is helping patients adapt rather than restoring sight.
Cataract surgery is a common outpatient procedure that involves replacing the cloudy natural lens with an artificial lens through mild sedation and topical anesthetic. There are several lens replacement options, including monofocal lenses which often require glasses after surgery, and premium lenses like toric lenses to reduce astigmatism or multifocal lenses that provide distance, intermediate, and near vision with over 80% of patients needing no glasses or contacts after surgery.
The Right Contact - Up to date information regarding contact lenses, Hyrid lenses, Soft lenses, button materials, gas permable lens and contact lens care products.
This document discusses the implantable miniature telescope (IMT) for treating end-stage age-related macular degeneration. It provides the following information:
1) The IMT received FDA approval in 2009 and Medicare coverage in 2011-2012 for patients with untreatable end-stage AMD who meet clinical criteria.
2) Clinical trials showed the IMT significantly improved vision for most patients, with 67% gaining 3 or more lines of vision and quality of life improvements.
3) The CentraSight treatment program assesses patients' candidacy and provides pre-and post-operative management including low vision rehabilitation to help patients utilize their restored vision.
Adaptive lenses can solve key issues preventing virtual and augmented reality from reaching their potential by changing focus like the human eye. They allow VR and XR experiences to be more immersive and comfortable by resolving the vergence-accommodation conflict. Adaptive lenses paired with eye tracking could also create autofocus glasses that automatically adjust focus for the user. Adaptive lenses are needed to fully realize the market potential of AR/VR estimated at over $50 billion by allowing content to be viewed comfortably at close distances.
Team 18 is developing a modular attachment for optical microscopes that uses Quantitative Phase Imaging (QPI) technology to provide faster, cheaper, and more accurate results for cancer and blood disorder research compared to state-of-the-art instrumentation. They have over 100 customers including universities, bio-pharma companies, and OEMs. Key members include experts in noninvasive biomedical imaging and entrepreneurship with experience commercializing start-up technologies.
This document discusses cataracts and presbyopia, as well as treatment options performed by Dr. Helga Fuenfhausen Pizio. A cataract is a clouding of the eye's lens that causes vision problems and is common in older adults. Symptoms include blurry or faded vision. Surgery is the only treatment and involves removing the clouded lens and replacing it with an artificial lens. For presbyopia, which causes near vision issues, multifocal lenses can provide both near and distance vision after cataract surgery without glasses. Dr. Pizio performs cataract surgery using small incisions and ultrasound and was the first in Nevada to implant a new multifocal lens.
The document provides information about low vision rehabilitation and tips for independence with low vision. It defines low vision as vision impairment that cannot be fully corrected and discusses how low vision specialists can assess functional vision and prescribe optical and electronic aids, as well as provide rehabilitation services, to help those with low vision maximize their remaining sight and function independently. Common causes and types of vision loss are described along with the roles of different eye care professionals in low vision care.
This document summarizes a presentation on identifying risk for falls in older adults with visual impairment and strategies for prevention. The presentation covered topics such as the scope of occupational therapy in low vision, common eye conditions and their functional impacts, vision screening tools, and intervention strategies like eccentric viewing training, visual scanning training, and environmental modifications. Referral resources for low vision services were also provided.
The advent of image-guided surgical technology has revolutionized conventional surgical techniques by providing surgeons with an intricate view of almost all body parts that includes the lobe of a brain, the nasal cavities, and even the structure of vertebrae in the spine. Computer-assisted image-guidance technology is a development to be on the lookout that will work in concert with minimally invasive techniques and is found to be much more powerful and elegant than simple X-ray technology. This minimally invasive technique enables the surgeons to obtain three-dimensional models of a patient’s anatomy that appears on a computer screen with virtual representations of real surgical instruments. Surgeries can even be fore planned virtually on the computer before a patient is subjected to anesthesia.
This presentation intends to specifically cover the unique integration of emerging technological advances in computer-assisted image-guidance and intraoperative image-guidance systems that will bring about fewer traumas to normal tissues, push forward the healing times, minor incisions, equivalent or better relief from pain, and last of all hasten the patient’s normal recovery. Highlights of the PPT include: outline of the surgical concepts behind image-guided surgery and robotic-assisted surgery; viewpoint on surgical robots designed to address surgeon’s limitations; enabling computer-assisted technologies for minimally invasive surgery, and future trends for image-guided surgical interventions sector.
Presentation by Dr. Detlev Breyer at the World Ophthalmology Congress in Barcelona, 2018: Introduction of a new diffractive trifocal intraocular lens. Comparison with a former diffractive trifocal IOL.
Aakash Eye Hospital is one of the largest
eye hospital in Ahmedabad, Visnagar and Bharuch.
our expertise in Cataract Surgery ,Glaucoma, Bladeless Lasik Surgery,
Squint Surgery, Pterygium, eye Treatment and Conjunctivitis Treatment.
Aakash Eye Hospital is one of the largest eye hospital in Ahmedabad, Visnagar and Bharuch. our expertise in Cataract Surgery ,Glaucoma, Bladeless Lasik Surgery, Squint Surgery, Pterygium, eye Treatment and Conjunctivitis Treatment
Anterior Segment Company Showcase - PowerVisionHealthegy
Anterior Segment Company Showcase - PowerVision at OIS@AAO 2016.
Presenter:
Barry Cheskin, Co-Founder, President & CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Dr. Anthony Roberts is an experienced ophthalmologist who specializes in refractive lens exchange (RLE) surgery. RLE involves replacing the natural lens in the eye with an artificial intraocular lens, similar to cataract surgery but to correct vision problems rather than treat cataracts. Depending on a patient's needs, RLE uses either a monofocal lens for single-distance vision, a multifocal lens for multiple fixed distances, or an accommodating lens for clear vision at all distances. RLE typically takes 15 minutes per eye to perform.
New Versus Former-Generation Diffractive Trifocal Intraocular Lens, presented at ASCRS 2018, by Timon Ax, D. Breyer, H. Kaymak, K. Klabe, P. Hagen, F. Kretz, G. Auffarth
Wide angle viewing field systems in vr surgerySamuel Ponraj
Wide angle viewing systems provide panoramic views of the retina during vitreous surgery. There are contact and non-contact systems. Contact systems include vitreous panfundoscopes, contact wide field lenses, advanced visual instrument systems, and reinverting operating lens systems. These provide good image resolution but require an inverter due to the inverted image and have risks of corneal trauma. Non-contact systems like the BIOM and Resight provide upright images without inversion but have poorer image quality. Newer non-contact systems aim to provide wide fields of view with upright high resolution images.
Volk Optical Inc. is a world leader in ophthalmic lenses and equipment located in Mentor, Ohio. Founded in 1975 by ophthalmologist David Volk, the company produces diagnostic, therapeutic, and surgical lenses and accessories. Volk Optical is known for Dr. Volk's original aspheric lens designs from the 1940s and offers a wide range of classic and digital lens types, including slit lamp, contact, imaging, and gonio lenses. The company prides itself on extensive warranties, high quality glass optics, new product development, and providing the best overall value in ophthalmic lenses.
This document provides an overview of orthokeratology (orthokeratology), which aims to temporarily reshape the cornea through the overnight use of specialized contact lenses to reduce or eliminate the need for refractive correction. It discusses the history of orthokeratology from its origins in the 1960s using conventional geometry lenses to more modern techniques employing reverse geometry lenses made of high Dk materials. The mechanisms by which orthokeratology reshapes the cornea, patient selection criteria, potential indications and contraindications are described. Advantages include reversibility and potentially slowing myopia progression in children, while disadvantages include its non-permanence and risk of non-compliance.
Orthokeratology uses rigid gas permeable contact lenses worn overnight to temporarily reshape the cornea and reduce or eliminate low to moderate degrees of myopia and astigmatism. The lenses have a molding effect on the cornea through epithelial redistribution, allowing patients to be correction-free during the day. However, the effect is not permanent and vision returns to the pre-treatment level if lenses are not worn. Ortho-k treatment generally takes one month for effects to stabilize and is most effective for prescriptions between -1.00 to -4.50 diopters of myopia and up to -1.50 diopters of astigmatism.
This document records the progress of a patient undergoing orthokeratology treatment over several visits. At the initial visit, the patient's vision and corneal topography were assessed. After being fitted with lenses, follow up visits evaluated vision, fitting, and topography. The topography initially showed a decentered pattern in the left eye, but after changing to flatter lenses, both eyes showed a centered treatment pattern. Orthokeratology uses rigid lenses to temporarily reshape the cornea and reduce refractive error by being worn overnight. Regular follow up assessments including topography are important to monitor treatment progress and address any fitting issues.
This document provides information on various types of phakic intraocular lenses (IOLs) that are implanted to correct refractive errors while leaving the natural lens in place. It discusses the history of phakic IOLs and describes anterior chamber angle-supported IOLs, iris-fixated IOLs, and posterior chamber phakic IOLs. The key points covered include the indications, surgical procedures, power calculation methods, potential complications, and advantages/disadvantages of each phakic IOL type.
This document discusses low vision aids and their use for people with visual impairments. It defines low vision according to the WHO and describes common causes of visual dysfunction like macular degeneration and glaucoma. The goals of low vision rehabilitation are to maintain and improve visual function through clinical assessment and optometric intervention. Low vision aids can be optical devices like magnifying glasses, telescopes, or non-optical devices that alter lighting, contrast and size of objects. Common optical devices discussed include magnifying spectacles, hand magnifiers, stand magnifiers, and telescopes.
Wake up to clear and sharp vision without the risk of surgery. Dr Adam Zhao at Amwell Eye Care is the top certified Ortho-K provider in NJ. Call today!
Orthokeratology, also known as corneal reshaping therapy, uses specially designed contact lenses to temporarily reshape the cornea and reduce or eliminate refractive errors. It allows patients to have clear unaided vision for most of the day by modifying the corneal curvature through overnight lens wear. Studies have shown orthokeratology can slow the progression of myopia in children by an average of 50%. A trial fitting is performed to assess the fluorescein pattern and ensure proper centration, bearing, and tear reservoir before beginning overnight wear to achieve the desired refractive change. Orthokeratology provides an alternative to glasses or surgery and is reversible.
Innovega is developing smart contact lenses and augmented reality/virtual reality glasses that are stylish and comfortable for the user. They have received funding from various government agencies and private investors. Their products aim to address large markets for visually impaired individuals estimated at $15 billion globally and the consumer AR/VR market estimated to reach $31 billion by 2023. Innovega plans to license their technology to manufacturers and distributors with revenue models including license fees, royalties, and engineering fees. They forecast revenue of $2 million in 2020, $5 million in 2021, and $12 million with $5 million in earnings in 2022 as their products reach commercialization.
Caduceus Medical Corp is developing non-invasive devices to monitor intraocular pressure and treat glaucoma and other eye conditions. Their first product, the IOP Sensor, continuously measures intraocular pressure over time to aid in earlier diagnosis and treatment. They have filed patents and plan to market to ophthalmologists and optometrists in the US initially. The management team has extensive experience in ophthalmic devices. They are seeking $14 million to complete development and clinical trials and launch the product.
The document provides information about low vision rehabilitation and tips for independence with low vision. It defines low vision as vision impairment that cannot be fully corrected and discusses how low vision specialists can assess functional vision and prescribe optical and electronic aids, as well as provide rehabilitation services, to help those with low vision maximize their remaining sight and function independently. Common causes and types of vision loss are described along with the roles of different eye care professionals in low vision care.
This document summarizes a presentation on identifying risk for falls in older adults with visual impairment and strategies for prevention. The presentation covered topics such as the scope of occupational therapy in low vision, common eye conditions and their functional impacts, vision screening tools, and intervention strategies like eccentric viewing training, visual scanning training, and environmental modifications. Referral resources for low vision services were also provided.
The advent of image-guided surgical technology has revolutionized conventional surgical techniques by providing surgeons with an intricate view of almost all body parts that includes the lobe of a brain, the nasal cavities, and even the structure of vertebrae in the spine. Computer-assisted image-guidance technology is a development to be on the lookout that will work in concert with minimally invasive techniques and is found to be much more powerful and elegant than simple X-ray technology. This minimally invasive technique enables the surgeons to obtain three-dimensional models of a patient’s anatomy that appears on a computer screen with virtual representations of real surgical instruments. Surgeries can even be fore planned virtually on the computer before a patient is subjected to anesthesia.
This presentation intends to specifically cover the unique integration of emerging technological advances in computer-assisted image-guidance and intraoperative image-guidance systems that will bring about fewer traumas to normal tissues, push forward the healing times, minor incisions, equivalent or better relief from pain, and last of all hasten the patient’s normal recovery. Highlights of the PPT include: outline of the surgical concepts behind image-guided surgery and robotic-assisted surgery; viewpoint on surgical robots designed to address surgeon’s limitations; enabling computer-assisted technologies for minimally invasive surgery, and future trends for image-guided surgical interventions sector.
Presentation by Dr. Detlev Breyer at the World Ophthalmology Congress in Barcelona, 2018: Introduction of a new diffractive trifocal intraocular lens. Comparison with a former diffractive trifocal IOL.
Aakash Eye Hospital is one of the largest
eye hospital in Ahmedabad, Visnagar and Bharuch.
our expertise in Cataract Surgery ,Glaucoma, Bladeless Lasik Surgery,
Squint Surgery, Pterygium, eye Treatment and Conjunctivitis Treatment.
Aakash Eye Hospital is one of the largest eye hospital in Ahmedabad, Visnagar and Bharuch. our expertise in Cataract Surgery ,Glaucoma, Bladeless Lasik Surgery, Squint Surgery, Pterygium, eye Treatment and Conjunctivitis Treatment
Anterior Segment Company Showcase - PowerVisionHealthegy
Anterior Segment Company Showcase - PowerVision at OIS@AAO 2016.
Presenter:
Barry Cheskin, Co-Founder, President & CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Dr. Anthony Roberts is an experienced ophthalmologist who specializes in refractive lens exchange (RLE) surgery. RLE involves replacing the natural lens in the eye with an artificial intraocular lens, similar to cataract surgery but to correct vision problems rather than treat cataracts. Depending on a patient's needs, RLE uses either a monofocal lens for single-distance vision, a multifocal lens for multiple fixed distances, or an accommodating lens for clear vision at all distances. RLE typically takes 15 minutes per eye to perform.
New Versus Former-Generation Diffractive Trifocal Intraocular Lens, presented at ASCRS 2018, by Timon Ax, D. Breyer, H. Kaymak, K. Klabe, P. Hagen, F. Kretz, G. Auffarth
Wide angle viewing field systems in vr surgerySamuel Ponraj
Wide angle viewing systems provide panoramic views of the retina during vitreous surgery. There are contact and non-contact systems. Contact systems include vitreous panfundoscopes, contact wide field lenses, advanced visual instrument systems, and reinverting operating lens systems. These provide good image resolution but require an inverter due to the inverted image and have risks of corneal trauma. Non-contact systems like the BIOM and Resight provide upright images without inversion but have poorer image quality. Newer non-contact systems aim to provide wide fields of view with upright high resolution images.
Volk Optical Inc. is a world leader in ophthalmic lenses and equipment located in Mentor, Ohio. Founded in 1975 by ophthalmologist David Volk, the company produces diagnostic, therapeutic, and surgical lenses and accessories. Volk Optical is known for Dr. Volk's original aspheric lens designs from the 1940s and offers a wide range of classic and digital lens types, including slit lamp, contact, imaging, and gonio lenses. The company prides itself on extensive warranties, high quality glass optics, new product development, and providing the best overall value in ophthalmic lenses.
This document provides an overview of orthokeratology (orthokeratology), which aims to temporarily reshape the cornea through the overnight use of specialized contact lenses to reduce or eliminate the need for refractive correction. It discusses the history of orthokeratology from its origins in the 1960s using conventional geometry lenses to more modern techniques employing reverse geometry lenses made of high Dk materials. The mechanisms by which orthokeratology reshapes the cornea, patient selection criteria, potential indications and contraindications are described. Advantages include reversibility and potentially slowing myopia progression in children, while disadvantages include its non-permanence and risk of non-compliance.
Orthokeratology uses rigid gas permeable contact lenses worn overnight to temporarily reshape the cornea and reduce or eliminate low to moderate degrees of myopia and astigmatism. The lenses have a molding effect on the cornea through epithelial redistribution, allowing patients to be correction-free during the day. However, the effect is not permanent and vision returns to the pre-treatment level if lenses are not worn. Ortho-k treatment generally takes one month for effects to stabilize and is most effective for prescriptions between -1.00 to -4.50 diopters of myopia and up to -1.50 diopters of astigmatism.
This document records the progress of a patient undergoing orthokeratology treatment over several visits. At the initial visit, the patient's vision and corneal topography were assessed. After being fitted with lenses, follow up visits evaluated vision, fitting, and topography. The topography initially showed a decentered pattern in the left eye, but after changing to flatter lenses, both eyes showed a centered treatment pattern. Orthokeratology uses rigid lenses to temporarily reshape the cornea and reduce refractive error by being worn overnight. Regular follow up assessments including topography are important to monitor treatment progress and address any fitting issues.
This document provides information on various types of phakic intraocular lenses (IOLs) that are implanted to correct refractive errors while leaving the natural lens in place. It discusses the history of phakic IOLs and describes anterior chamber angle-supported IOLs, iris-fixated IOLs, and posterior chamber phakic IOLs. The key points covered include the indications, surgical procedures, power calculation methods, potential complications, and advantages/disadvantages of each phakic IOL type.
This document discusses low vision aids and their use for people with visual impairments. It defines low vision according to the WHO and describes common causes of visual dysfunction like macular degeneration and glaucoma. The goals of low vision rehabilitation are to maintain and improve visual function through clinical assessment and optometric intervention. Low vision aids can be optical devices like magnifying glasses, telescopes, or non-optical devices that alter lighting, contrast and size of objects. Common optical devices discussed include magnifying spectacles, hand magnifiers, stand magnifiers, and telescopes.
Wake up to clear and sharp vision without the risk of surgery. Dr Adam Zhao at Amwell Eye Care is the top certified Ortho-K provider in NJ. Call today!
Orthokeratology, also known as corneal reshaping therapy, uses specially designed contact lenses to temporarily reshape the cornea and reduce or eliminate refractive errors. It allows patients to have clear unaided vision for most of the day by modifying the corneal curvature through overnight lens wear. Studies have shown orthokeratology can slow the progression of myopia in children by an average of 50%. A trial fitting is performed to assess the fluorescein pattern and ensure proper centration, bearing, and tear reservoir before beginning overnight wear to achieve the desired refractive change. Orthokeratology provides an alternative to glasses or surgery and is reversible.
Innovega is developing smart contact lenses and augmented reality/virtual reality glasses that are stylish and comfortable for the user. They have received funding from various government agencies and private investors. Their products aim to address large markets for visually impaired individuals estimated at $15 billion globally and the consumer AR/VR market estimated to reach $31 billion by 2023. Innovega plans to license their technology to manufacturers and distributors with revenue models including license fees, royalties, and engineering fees. They forecast revenue of $2 million in 2020, $5 million in 2021, and $12 million with $5 million in earnings in 2022 as their products reach commercialization.
Caduceus Medical Corp is developing non-invasive devices to monitor intraocular pressure and treat glaucoma and other eye conditions. Their first product, the IOP Sensor, continuously measures intraocular pressure over time to aid in earlier diagnosis and treatment. They have filed patents and plan to market to ophthalmologists and optometrists in the US initially. The management team has extensive experience in ophthalmic devices. They are seeking $14 million to complete development and clinical trials and launch the product.
Black Hawk's is developing nightvision contact lenses in three variants for defense, security, and research applications. Version T has thermal imaging and adjustable focus, Version S has a spy camera and adjustable focus, and Version TS has both. The lenses leverage emerging nightvision and graphene technologies. Black Hawk's aims to become a top eye care brand globally through innovation. It will target professionals, executives, defense and security personnel in major Indian cities through online and B2B sales.
Anterior Segment Company Showcase - AcuFocusHealthegy
Anterior Segment Company Showcase - AcuFocus at OIS@AAO 2016.
Presenter:
Al Waterhouse, President
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Carolien Creemers and Maarten Bressinck work as functional designers at Nobel Biocare, focusing on user experience and interaction design for digital dental solutions. They discussed challenges with designing medical software due to strict regulations and outlined Nobel Biocare's process, which incorporates agile development methods and user research like field studies and usability testing to ensure safety and meet regulations. They provided examples of their solutions, like using cards to visualize dental lab workflows and mapping surgical cuts onto a digital tool.
Sharps Technology is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through compassionate innovation. Sharps’ line of smart safety syringes eliminates accidental needlestick injuries, prevents needle reuse, and reduces wasted vaccines and medicine while retaining the intuitive simplicity of traditional syringes. Sharps Technology aims to be a solution provider for the advancement of future drug delivery systems.
Rudi Schubert (IEEE Standards Association) Challenges for Smartglasses AdoptionAugmentedWorldExpo
A discussion on the role of smart glasses in the Industry 4.0 context firstly requires a classification on the different types of smart glasses. A taxonomy for smart eyewear allows to map use cases and business requirements of the industry with the strengths and weaknesses of each class. The gap between business reality and hardware aspiration is the basis to discuss future trends and the expected evolution. Smart glasses are a key component to provide human-centered support and to connect the desk-less operator with the IoT and other elements of the cyber-physical factory of the future.
The document discusses a proposed portable ultrasound device project. It aims to create an affordable and easy-to-use portable ultrasound device to fill a gap in the market. The founders are responsible for hardware, software, and regulatory compliance. Market analysis shows strong growth in portable and handheld ultrasound devices. Feedback from customers emphasizes that the device needs to be easy to use, affordable, and better than existing options. The business model may focus on internal medicine, rural, and emergency doctors by prioritizing ease of use, image quality, and portability.
Presentation from OIS@ASCRS 2016
Co-Moderators:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Stephen Slade, MD
Company Presentations
Equinox | John Berdahl, MD, Founder & CEO
Presbyopia Therapies | Jim McCollum, Co-Founder
Stroma Medical | Doug Daniels, CEO
Eyenovia | Curt LaBelle, MD, Director
Wicab | Robert Beckman, President & COO
The Future of Biosensing Wearables by @Rock_HealthRock Health
The Future of Biosensing Wearables encompasses a review of the current landscape of wearables, how we expect products to evolve into narrower use cases (by improving functionality, reliability, and convenience), and business models for wearable companies in the face of technology giants Apple and Samsung moving aggressively into digital health.
Review our archived webinar on YouTube for a deeper look: https://www.youtube.com/watch?v=B1KBrbgF2Q4
Download this report for $99: https://gumroad.com/l/MnMa
The document describes a proposed eye health monitoring device called iHealth. It would use a webcam to detect users' iris dilation and gaze, which indicate eye fatigue. When fatigue levels exceed a threshold, the device would dim the computer screen brightness to reduce eye strain. User studies were conducted and similar existing technologies were reviewed. Potential critiques and future directions are discussed, such as adding mobile synchronization and extending the device to monitor TV usage.
The document provides information on Francesco Sardu's background and experience in service design. It outlines his expertise in various industries such as healthcare, logistics, mobility, banking, and more. It also describes the key phases and methods of Francesco's service design methodology, including understanding user needs, defining requirements, concept development, prototyping, and testing. Several of Francesco's past projects are briefly described, including his role in European projects focused on developing healthcare services using technologies like smartglasses, robots, and mobile applications.
HxRefactored - APX Labs - Jeff JenkinsHxRefactored
The document discusses how smart glasses and the Skylight software platform can improve healthcare. Skylight allows smart glasses to access real-time contextual data and systems to enhance hands-free collaboration. It enables functions like remote consultation, virtual home visits, recording training sessions, and accessing patient data without looking away from the patient. These capabilities could expand physicians' reach, reduce readmissions, revolutionize training, and keep doctors hands-free, improving efficiency and quality of care. Skylight also integrates with other systems and provides alerts to help maximize healthcare providers' revenue.
Posterior Segment Company Showcase - AGTCHealthegy
Posterior Segment Company Showcase - AGTC at OIS@AAO 2016.
Presenter:
Sue Washer, President & CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
LumenLab is MetLife's innovation center in Asia focused on disruptive innovation and creating new business models. It uses a stage-gate approach to incubate ideas from concept to scalable businesses. Current projects span health, aging, and fintech. LumenLab also aims to establish a growth mindset at MetLife through workshops and programs that have significantly improved organizational health indices. Early results show LumenLab projects already generating value for the business.
From the clinic to the cfo adaptive trials and financial decision makingCytel USA
This document discusses how adaptive trial designs can be used to integrate clinical trial planning with financial decision making. It presents two case studies:
1) A biotech company used an adaptive design for a pivotal trial of an AML drug to reduce upfront costs and attract external investment. Interim results determined whether to increase the sample size. This improved the drug's risk/reward profile.
2) Hypothetical options for developing a niche oncology asset were evaluated. Scenarios including group sequential designs with interim analyses provided trade-offs between probability of success, time, cost, and expected value to discuss with management. Integrating financial metrics into adaptive trial design allows more flexible, "investable" research options.
VISX Star S4 with Iris Registration Print Ad Marketing PlanJeffray Ang
The 10 step marketing plan outlines strategies to promote the VISX Star S4 IR laser system for a Lasik surgery clinic. It targets patients with blurred vision seeking laser vision correction. The plan involves positioning the VISX system as the latest FDA-approved technology preferred by US surgeons. It estimates the laser correction market at PHP500 billion and prices the VISX system at PHP80,000 per patient. The clinic will use referrals, ads and the internet to promote the niche VISX system exclusively at its Philippines location.
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
Kopin is a leader in wearable headset technology. They supply key components and solutions for wearable headsets, including small ultra-high brightness displays, optics, and concept/reference systems. Kopin has over 25 years of experience in this field and a strong portfolio of patents and technologies to help customers bring wearable headset products to market more quickly and easily. The presentation encourages visiting their booth at the conference.
Kopin is a leader in wearable headset technology. They supply key components and solutions for wearable headsets, including small display modules, concept and reference systems, and have strong intellectual property and know-how in the area. Kopin aims to help customers bring wearable headset products to market more quickly and easily by providing these core technologies and system designs.
1. 1
SMART CONTACT LENSES
and STYLISH GLASSES
Patients and Consumers
COPYRIGHT Innovega Inc. 2018. eMacula is a trademark, and iOptik is a registered trademark, of Innovega Inc.
Engineered by Innovega Inc.
2. 2
FORWARD-LOOKING STATEMENTS
This presentation contains forward-looking statements and information relating to, among
other things, Innovega Inc, its business plan and strategy, and its industry.
These statements reflect management’s current views with respect to future events based on
information currently available and are subject to risks and uncertainties that could cause the
company’s actual results to differ materially.
Investors are cautioned not to place undue reliance on these forward-looking statements as
they are meant for illustrative purposes and they do not represent guarantees of future results,
levels of activity, performance, or achievements, all of which guarantees cannot be made.
Moreover, no person or entity assumes responsibility for the accuracy and completeness of
these forward-looking statements, and no persons or entities are under any duty to update any
such statements to conform them to actual results.
2
3. 3
TRANSFORMATIVE EYEWEAR SYSTEM
• Transformative for
• Partially-sighted patients who have lost
their lifestyle
• An Industry whose growth has stalled
and is in need of innovation
• Normal, Stylish Glasses for medical,
consumer and industrial applications
• 30 domestic plus additional international
patents plus trade-secrets
• The company will initially license its technology
into the $74B global vision care market
• Advisor teams include senior executives
from Microsoft, Sony and Bausch + Lomb
3
4. 4
EMACULA™ SYSTEM
UNPRECEDENTED ASSISTANCE FOR 15 M
VISUALLY IMPAIRED PATIENTS
• Problem: Patients with visual impairment require
magnification to see what a sighted person sees
• The magnification required by patient is too great for
normal prescription eyeglasses or contact lenses
• Innovega Cameral on Glasses Solution: Camera mounted
on glasses captures, magnifies, and enhances the
patient’s world to instantly deliver functional vision
• Patient wears Innovega smart contact lens and glasses
that instantly deliver magnified, enhanced and
panoramic sight from lightweight, stylish eyewear system
4
5. 55
SMART PERSONALIZED CONTACT LENSES
PROPRIETARY NANO-TECHNOLOGY POLARIZERS
Outer Filter & Lens
Capturing Real-World View
Contact Lens
Will include Personal Prescription
Center Filter & Lenslet
Capturing Digital Media
5
7. 7
INNOVEGA TEAM
Steve Willey: Co-Founder, CEO & Director — Passion for commercializing
game-changing technologies (Co-founder and president, MicroVision
(NASDAQ: MVIS); “turn-around” CEO of AirIQ Inc (TSXV:IQ) ; multiple
business and general management of start-ups that were later acquired by
Fortune 100 companies.
Jay Marsh: VP Engineering — Former VP Engineering with APRI, and more
than 25 years developing systems that achieved unprecedented
performance; leadership of multidisciplinary engineering teams dedicated
to delivering complex electro / optical / mechanical systems
Dr. Jerome A. Legerton: Co-Founder, Director — Successful career in
contact lens development and commercialization; 56 issued U.S. patents,
co-inventor of Paragon CRT® contact lenses, the market leader for
overnight corneal reshaping. Co-founder and former CTO and EVP of
SynergEyes, Inc., the world leader in hybrid contact lenses.
7
8. 8
LARGE PATIENT AND CONSUMER MARKETS
8
https://www.prnewswire.com/news-
releases/global-74-bn-vision-care-market-to-2024-
300817009.html
https://www.grandviewresearch.com/industry-
analysis/contact-lenses-market
https://www.marketwatch.com/press-release/ar-and-vr-smart-
glasses-market-2019-global-size-share-trends-growth-
opportunities-key-players-industry-segments-and-forecast-2023-
2019-02-11
$74B global
Vision Care
market
$11B Global
Contact Lens
market
USD $31B Consumer
Smart Glasses market
(Forecast 2023)
9. 9
INNOVEGA REVENUE MODEL
• License of intellectual property to
eyewear and contact lens
manufacturers, and to distributors
that will sell and market the
combined system
• Multiple revenue streams:
Upfront license fee; future
royalties based on sales or profits;
NRE (Non-recurring engineering)
fees to fund Innovega
collaboration
• Innovega also develops and
fabricates working contact lens
and eyewear prototypes and
limited production runs
• Upfront licenses fees could be seven figures
or more
• Glasses royalties could be a percentage of
price paid by the patient
• Contact lens royalties could be a percentage
of recurring revenue from disposable lenses
• Non-recurring engineering (NRE) fees could
be seven figures or more
9
10. 10
GO-TO-MARKET STRATEGY
CAPITAL-EFFICIENT STRATEGIC PARTNERSHIP MODEL
1. CORE: 15 M VISUALLY IMPAIRED PATIENTS
• Glasses fitted with high magnification camera
• Provide panoramic and magnified world-view
• Meets patient lifestyle demand for “glasses”
2. UPSIDE MARKETS: MASS MARKET CONSUMERS
• Consumers want mobility and glasses style
• Consumers expect big, rich media
• TENCENT is a lead investor / potential partner
10
Today’s Unacceptable Goggles
12. 12
WEARERS NEED THESE “10” FEATURES
Comfort
1. Lightweight, balanced (2-3 oz)
2. No Eyestrain or headaches (“solve” vergence-accommodation conflicts!)
3. Integrated Vision Correction (62% of humans require vision correction)
4. Socially Comfortable: Any Style, Normal Glasses
High Performance
5. High-resolution / Eye-limited, Retinal Display (1.2 arc-minute resolution)
6. Panoramic, Unobstructed Field of View (over 100 degrees)
7. Highest Image Quality, High-efficiency screens (ex. OLED)
Many Configurations and Applications
8. VR/AR/MR (today’s and future configurations)
9. Any Image Source (Microdisplay screens, Pico-projectors)
10. Expandable and Extendable (ex. Integrated Eye-tracking, ex. 5g Edge device)
12
13. 13
EMACULATM UNIQUELY DELIVERS ALL “10” FEATURES
Comfort
1. Lightweight, balanced (2-3 oz)
2. No Eyestrain or headaches (“solve” vergence-accommodation conflicts!)
3. Integrated Vision Correction (62% of humans require vision correction)
4. Socially Comfortable: Any Style, Normal Glasses
High Performance
5. High-resolution / Eye-limited, Retinal Display (1.2 arc-minute resolution)
6. Panoramic, Unobstructed Field of View (over 100 degrees)
7. Highest Image Quality, High-efficiency screens (ex. OLED)
Many Configurations and Applications
8. VR/AR/MR (today’s and future configurations)
9. Any Image Source (Microdisplay screens, Pico-projectors)
10. Expandable and Extendable (ex. Integrated Eye-tracking, ex. 5g Edge device)
13
14. 14
PARTNER BUSINESS MODEL - STATUS
• Innovega delivers core technology,
prototypes, applications
• Partners “brand” glasses / lenses
• Multiple revenue streams
• Existing relationships or discussions
with these global companies =>
14
15. 15
KEY INVESTORS, DIRECTORS, AND LEADERSHIP
World’s largest video game
company & world’s largest
social media company
Med-Tech Investment Firm
VC focused on gaming and
social media
Jeff Xiong, FORMER CTO, TENCENT
Shane Kim, INTERIM CEO, GAMESTOP; FORMER VP MSFT XBOX
Jerome Legerton, OD, CO-FOUNDER SynergEyes
Steve Willey, CO-FOUNDER MicroVision
Steve Willey, MBA
CEO
Jerome Legerton, OD
CHIEF CLINICAL OFFICER
Jay Marsh, M Sc EE
VP ENGINEERING
Bill Meyers, PhD
VP CONTACT LENSES
Mark Freeman, PhD
DIRECTOR OPTICS & PHOTONICS
Peter Schuster, CPA
DIRECTOR FINANCE
INVESTORS DIRECTORS
LEADERSHIP TEAM
15
16. 16
BUSINESS, CLINICAL, SCIENTIFIC ADVISORY BOARDS
Phil Molyneux, Consumer Electronics
REGIONAL PRESIDENT DYSON. FORMER PRESIDENT, SONY
ELECTRONICS, INC. N.A.
Avram Miller, Capital Formation
CO-FOUNDER INTEL CAPITAL. FORMER VP, BUSINESS
DEVELOPMENT, INTEL CORP.
Dan Spira, Healthcare
FORMER NORTH AMERICA VP, BAUSCH & LOMB WITH
RESPONSIBILITIES ACROSS EYE HEALTH, SKINCARE AND
AESTHETICS; FORMER VP, JOHNSON & JOHNSON
Jayson Chi, Video Game industry
FORMER PARTNER MCKINSEY GROUP
(GLOBAL LEAD, VIDEO GAMING PRACTICE)
Robert Simmonds, Mobile Carrier
FOUNDER, FORMER CHAIRMAN OF CLEARNET
COMMUNICATIONS. ACQUIRED BY TELUS CORP FOR $6B
Joe Barr, OD, MS
FORMER GLOBAL VP FOR CLINICAL AND MEDICAL AFFAIRS, BAUSCH &
LOMB; EMERITUS PROFESSOR THE OHIO STATE UNIVERSITY
Mark Bullimore, MCOptom, PhD
FORMER FDA OPHTHALMIC DEVICE PANEL MEMBER; FDA EXPERT ON
VISION ASSESSMENT; DEAN MARSHALL B. KETCHUM UNIVERSITY,
COLLEGE OF OPTOMETRY
Richard Lindstrom, MD
FOUNDER AND ATTENDING SURGEON MINNESOTA EYE CONSULTANTS;
ADJUNCT PROFESSOR EMERITUS, UNIVERSITY OF MINNESOTA
DEPARTMENT OF OPHTHALMOLOGY, OPHTHALMOLOGY EXPERT IN
MEDICAL DEVICES AND CORNEAL AND CATARACT SURGERY
Steve Schallhorn, MD
OPHTHALMOLOGY EXPERT IN MEDICAL DEVICES AND CORNEAL AND
CATARACT SURGERY; FORMER DIRECTOR, NAVAL REFRACTIVE SURGERY
CENTER SAN DIEGO
Jim Schwiegerling, PhD
PROFESSOR, UNIVERSITY OF ARIZONA - OPHTHALMOLOGY AND
VISION SCIENCE; OPTICS EXPERT
16
17. 17
STATUS OF EMACULA U.S. FDA PROCESS
• In-person Pre‐submisson FDA meeting has occurred
• Phase II clinical trials underway; Pre-clinical testing underway
• Phase III FDA clinical trial will start upon Phase II trial completion
• Phase III (Part 1)
• 510(k) process for approval of lens material
• 510(k) process is a premarket submission made to FDA
to demonstrate that a non-significant risk device (Class
II) to be marketed is substantially equivalent in safety
and effectiveness to an already FDA cleared Class II
device for the same medical indications.
• Phase III (Part 2)
• FDA De Novo process for approval of the iOptik® display lens
• No previously cleared device for viewing a near eye display
17
18. PROGRESS AND PLANNEDMILESTONES
This slide reflects management’s current views with respect to future events based on information currently available and is subject to risks and uncertainties.
This slide is meant for illustrative purposes and does not represent guarantees of future results, levels of activity, performance, or achievements.
18
19. 19
9,874,765 Dual path contact lens
2014/0138544 MEMS based Eye Tracking, 2
2017/0337706
Low Latency Gaze Tracker
Patterned
Polarizer
8,142,016
Lens-let Molding into Contact Lens
Contact Lens
Component Containing Molding
2016/0216534
Contact Lens with Non-
Permeable Inserts
8,922,898
Wire Grid Polarizer in Lens
8,482,858 Deflection Optics
9,869,884
Contact Lens
2015/0084999 See Through Display
with Pixilation Occlusion, 2
9,251,745 See Through Display
with Pixilation Occlusion, 1
8,441,731 Direct View
Transparent Display
2018/0090052
Large Field of View Head-worn Display
2016/0131910 TFD based display8,922,897 Pixilated Occlusion for TFD
8,520,309 Display and Non
Display Path Foundational Case
8,786,520
Direct View Display in Eyewear
9,040,923 MEMS based Eye Tracking, 1
High Resolution
Transparent Display
Implanted Optical
Device
Camera Eyewear
Methods of Fitting Display Eyewear
SUCCESSFUL PATENT MANAGEMENT
Display
Systems
Eye Tracking
Filters
Filed - Unpublished by USPTO
Application in process
Core (14)
1st Order (7)
2nd Order (5)
8,888,279 Filters with Lenslet
9,348,151 Molded lens with nanofilaments, 1
2015/0205146 Molded lens with nanofilaments, 2
20. 20
SUMMARY
• Experienced team has delivered $6M working systems
• Valuable portfolio of domestic and foreign patents
• Core Market of 15 million Visually Impaired Patients
• Uniquely meets needs of Upside Consumer Markets
• FDA Phase II trials near completion; Final Phase planned
• Strategic partners invested $5.5M - led by Tencent
• Discussions with Operating Partners and Investors
• We welcome your involvement
20